AbbVie
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Illinois, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
1 N Waukegan Rd, North Chicago, Illinois...Phone Number
(847) 932-7900Website
www.abbvie.comRevenue
$64.4 BillionStock Symbol
ABBVIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
5
4
5
3
2
1
About AbbVie
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.Explore more
AbbVie Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AbbVie your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AbbVie had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at AbbVie
AbbVie, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if AbbVie is spiking on competitors!
Funding: Get notified immidiatlly once AbbVie has new funding data
Earning: See what the market has to say on AbbVie recently announced quarterly report
Check if AbbVie has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AbbVie launches new products
Recommended Actions
Reach out to Masked Content who joined AbbVie as Masked Content
Find 3 more new buyers
Explore company insights
Get a deeper look into AbbVie's structure, leadership, and market position:
Company Profile Activity
Activity Insights
AbbVie is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AbbVie is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AbbVie.
AbbVie Tech Stack
A closer look at the technologies used by AbbVie
Most Recent Scoops
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
AbbVie News & Media
AbbVie's Etentamig Delivers 74% Response Rate in Pivotal Cancer Trial
Etentamig beat standard treatment by 28.3 percentage points and met the Phase 3 study's progression-free-survival goal.AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
AbbVie completed its $10.9 billion Apogee acquisition, adding IL-13 antibody zumilokibart and other inflammatory disease assets.AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
Etentamig, an investigational asset, achieved a significantly improved objective response rate (ORR, 74%) and a 60% risk reduction in disease progression or death (progression-free survival, hazard ratio 0.40) versus investigator's choice of standard available therapies Etentamig...AbbVie Completes Acquisition of Apogee Therapeutics
Acquisition deepens AbbVie's robust immunology pipeline with diverse assets targeting dermatologic, respiratory and other inflammatory and immunological diseases Apogee's lead asset, zumilokibart, is a late-stage, half-life extended monoclonal antibody targeting IL-13, in development for...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AbbVie
Sign Up For FreeTo access detailed company insights
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outc... Read More
